Conserved ESX-1 Substrates EspE and EspF Are Virulence Factors That Regulate Gene Expression.
Alexandra E ChirakosKathleen R NicholsonAllison HuffmanPatricia A ChampionPublished in: Infection and immunity (2020)
Mycobacterium tuberculosis, the cause of human tuberculosis, and Mycobacterium marinum, a nontubercular pathogen with a broad host range, require the ESX-1 secretion system for virulence. The ESX-1 system secretes proteins which cause phagosomal lysis within the macrophage via an unknown mechanism. As reported elsewhere (R. E. Bosserman et al., Proc Natl Acad Sci U S A 114:E10772-E10781, 2017, https://doi.org/10.1073/pnas.1710167114), we recently discovered that the ESX-1 system regulates gene expression in M. marinum This finding was confirmed in M. tuberculosis in reports by C. Sala et al. (PLoS Pathog 14:e1007491, 2018, https://doi.org/10.1371/journal.ppat.1007491) and A. M. Abdallah et al. (PLoS One 14:e0211003, 2019, https://doi.org/10.1371/journal.pone.0211003). We further demonstrated that a feedback control mechanism connects protein secretion to WhiB6-dependent expression of the esx-1 genes via an unknown mechanism. Here, we connect protein secretion and gene expression by showing for the first time that specific ESX-1 substrates have dual functions inside and outside the mycobacterial cell. We demonstrate that the EspE and EspF substrates negatively control esx-1 gene expression in the M. marinum cytoplasm through the conserved WhiB6 transcription factor. We found that EspE and EspF are required for virulence and promote lytic activity independently of the major EsxA and EsxB substrates. We show that the dual functions of EspE and EspF are conserved in the orthologous proteins from M. tuberculosis Our findings support a role for EspE and EspF in virulence that is independent of the EsxA and EsxB substrates and demonstrate that ESX-1 substrates have a conserved role in regulating gene expression.
Keyphrases
- gene expression
- mycobacterium tuberculosis
- transcription factor
- dna methylation
- escherichia coli
- pseudomonas aeruginosa
- staphylococcus aureus
- antimicrobial resistance
- pulmonary tuberculosis
- biofilm formation
- genome wide
- spinal cord injury
- endothelial cells
- emergency department
- binding protein
- poor prognosis
- hiv aids
- cell therapy
- adverse drug
- protein protein
- cystic fibrosis
- genome wide identification
- mesenchymal stem cells
- hiv infected